Stockreport

Nightstar Therapeutics Announces Initiation of STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia

NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA  (NITE) 
Last nightstar therapeutics plc american depositary sha earnings: 11/13 01:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nightstartx.com/investor-relations
PDF LEXINGTON, Mass. and LONDON, March 05, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments f [Read more]